{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:18:06Z","timestamp":1791249486113,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T00:00:00Z","timestamp":1579132800000},"content-version":"vor","delay-in-days":3486,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA121039"],"award-info":[{"award-number":["R01CA121039"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.2353\/ajpath.2010.100048","type":"journal-article","created":{"date-parts":[[2010,6,21]],"date-time":"2010-06-21T22:30:21Z","timestamp":1277159421000},"page":"377-386","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Down-Regulation of CD9 Expression and its Correlation to Tumor Progression in B Lymphomas"],"prefix":"10.1016","volume":"177","author":[{"given":"Sun-Ok","family":"Yoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold S.","family":"Freedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Zahrieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izidore S.","family":"Lossos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Sung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.2353\/ajpath.2010.100048_bib1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1600-065X.1998.tb01446.x","article-title":"Insight into the origin and clonal history of B-cell tumors as revealed by analysis of immunoglobulin variable region genes","volume":"162","author":"Stevenson","year":"1998","journal-title":"Immunol Rev"},{"key":"10.2353\/ajpath.2010.100048_bib2","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM199911113412007","article-title":"Cellular origin of human B-cell lymphomas","volume":"341","author":"Kuppers","year":"1999","journal-title":"N Engl J Med"},{"key":"10.2353\/ajpath.2010.100048_bib3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1084\/jem.180.1.329","article-title":"Analysis of somatic mutation in five B cell subsets of human tonsil","volume":"180","author":"Pascual","year":"1994","journal-title":"J Exp Med"},{"key":"10.2353\/ajpath.2010.100048_bib4","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/eji.1830270140","article-title":"Accumulation of somatic hypermutation and antigen-driven selection in rapidly cycling surface Ig+ germinal center (GC) B cells which occupy GC at a high frequency during the primary anti-hapten response in mice","volume":"27","author":"Kimoto","year":"1997","journal-title":"Eur J Immunol"},{"key":"10.2353\/ajpath.2010.100048_bib5","first-page":"69","article-title":"Follicular dendritic cells: antigen retention. B cell activation, and cytokine production","volume":"201","author":"Kosco-Vilbois","year":"1995","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.2353\/ajpath.2010.100048_bib6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF02786360","article-title":"Differentiation and apoptosis of human germinal center B-lymphocytes","volume":"16","author":"Choi","year":"1997","journal-title":"Immunol Res"},{"key":"10.2353\/ajpath.2010.100048_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2141.1992.tb06395.x","article-title":"Proliferation of non-Hodgkin-lymphocytes in vitro is dependent upon follicular dendritic cell interactions","volume":"80","author":"Petrasch","year":"1992","journal-title":"Br J Haema"},{"key":"10.2353\/ajpath.2010.100048_bib8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1078\/0344-0338-00421","article-title":"Disappearance of CD21-positive follicular dendritic cells preceding the transformation of follicular lymphoma: immunohistological study of the transformation using CD21, p53, Ki-67, and P-glycoprotein","volume":"199","author":"Shiozawa","year":"2003","journal-title":"Pathol Res Pract"},{"key":"10.2353\/ajpath.2010.100048_bib9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4049\/jimmunol.164.1.56","article-title":"Distinct role of follicular dendritic cells and T cells in the proliferation, differentiation, and apoptosis of a centroblast cell line. L3055","volume":"164","author":"Choe","year":"2000","journal-title":"J Immunol"},{"key":"10.2353\/ajpath.2010.100048_bib10","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1182\/blood-2004-01-0292","article-title":"Novel follicular dendritic cell molecule, 8D6, collaborates with CD44 in supporting lymphomagenesis by a Burkitt lymphoma cell line, L3055","volume":"104","author":"Li","year":"2004","journal-title":"Blood"},{"key":"10.2353\/ajpath.2010.100048_bib11","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1096\/fasebj.11.6.9194523","article-title":"The tetraspanin superfamily: molecular facilitators","volume":"11","author":"Maecker","year":"1997","journal-title":"FASEB J"},{"key":"10.2353\/ajpath.2010.100048_bib12","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1177\/002215549704500404","article-title":"Localization of the transmembrane 4 superfamily (TM4SF) member PETA-3 (CD151) in normal human tissues: comparison with CD9, CD63, and alpha5beta1 integrin","volume":"45","author":"Sincock","year":"1997","journal-title":"J Histochem Cytochem"},{"key":"10.2353\/ajpath.2010.100048_bib13","doi-asserted-by":"crossref","first-page":"5605","DOI":"10.4049\/jimmunol.168.11.5605","article-title":"CD9 is a unique marker for marginal zone B cells, B1 cells, and plasma cells in mice","volume":"168","author":"Won","year":"2002","journal-title":"J Immunol"},{"key":"10.2353\/ajpath.2010.100048_bib14","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/sj.leu.2403822","article-title":"Aberrant expression of tetraspanin molecules in B-cell chronic lymphoproliferative disorders and its correlation with normal B-cell maturation","volume":"19","author":"Barrena","year":"2005","journal-title":"Leukemia"},{"key":"10.2353\/ajpath.2010.100048_bib15","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/PL00000933","article-title":"Tetraspanins","volume":"58","author":"Boucheix","year":"2001","journal-title":"Cell Mol Life Sci"},{"key":"10.2353\/ajpath.2010.100048_bib16","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nrm1736","article-title":"Tetraspanin functions and associated microdomains","volume":"6","author":"Hemler","year":"2005","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.2353\/ajpath.2010.100048_bib17","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nrc2543","article-title":"Tetraspanins: push and pull in suppressing and promoting metastasis","volume":"9","author":"Zoller","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.2353\/ajpath.2010.100048_bib18","first-page":"1244","article-title":"Motility-related protein-1 (MRP-1\/CD9) reduction as a factor of poor prognosis in breast cancer","volume":"56","author":"Miyake","year":"1996","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2010.100048_bib19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/(SICI)1097-0215(19970422)74:2<205::AID-IJC12>3.0.CO;2-C","article-title":"Immunohistochemically detected expression of motility-related protein-1 (MRP-1\/CD9) in lung adenocarcinoma and its relation to prognosis","volume":"74","author":"Higashiyama","year":"1997","journal-title":"Int J Cancer"},{"key":"10.2353\/ajpath.2010.100048_bib20","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0002-9440(10)65639-8","article-title":"Correlation of reduction in MRP-1\/CD9 and KAI1\/CD82 expression with recurrences in breast cancer patients","volume":"153","author":"Huang","year":"1998","journal-title":"Am J Pathol"},{"key":"10.2353\/ajpath.2010.100048_bib21","first-page":"1507","article-title":"Motility related protein 1 (MRP1\/CD9) expression in colon cancer","volume":"4","author":"Mori","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.2353\/ajpath.2010.100048_bib22","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S1016-8478(23)17393-6","article-title":"Monoclonal antibody to CD9 inhibits platelet-induced human endothelial cell proliferation","volume":"22","author":"Ko","year":"2006","journal-title":"Mol Cells"},{"key":"10.2353\/ajpath.2010.100048_bib23","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.4049\/jimmunol.153.7.2951","article-title":"Activation and proliferation of follicular dendritic cell-like cells by activated T lymphocytes","volume":"153","author":"Kim","year":"1994","journal-title":"J Immunol"},{"key":"10.2353\/ajpath.2010.100048_bib24","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/sj.leu.2402002","article-title":"Establishment of a follicular lymphoma cell line (FLK-1) dependent on follicular dendritic cell-like cell line HK","volume":"15","author":"Kagami","year":"2001","journal-title":"Leukemia"},{"key":"10.2353\/ajpath.2010.100048_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1073\/pnas.98.1.31","article-title":"Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection","volume":"98","author":"Li","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2010.100048_bib26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/gyno.2001.6352","article-title":"Global expression changes of constitutive and hormonally regulated genes during endometrial neoplastic transformation","volume":"83","author":"Mutter","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.2353\/ajpath.2010.100048_bib27","doi-asserted-by":"crossref","first-page":"6579","DOI":"10.1158\/0008-5472.CAN-05-2415","article-title":"DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1\/cip1 promoter, is a candidate tumor suppressor","volume":"66","author":"Chao","year":"2006","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2010.100048_bib28","doi-asserted-by":"crossref","first-page":"9385","DOI":"10.1158\/0008-5472.CAN-06-0590","article-title":"TSLC1 is a tumor suppressor gene associated with metastasis in nasopharyngeal carcinoma","volume":"66","author":"Lung","year":"2006","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2010.100048_bib29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1167\/iovs.04-0330","article-title":"Specific targeting of gene expression to a subset of human trabecular meshwork cells using the chitinase 3-like 1 promoter","volume":"46","author":"Liton","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.2353\/ajpath.2010.100048_bib30","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.4049\/jimmunol.169.5.2507","article-title":"RGS13 regulates germinal center B lymphocytes responsiveness to CXC chemokine ligand (CXCL)12 and CXCL13","volume":"169","author":"Shi","year":"2002","journal-title":"J Immunol"},{"key":"10.2353\/ajpath.2010.100048_bib31","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1158\/0008-5472.CAN-04-4200","article-title":"Omega-3 polyunsaturated fatty acids regulate syndecan-1 expression in human breast cancer cells","volume":"65","author":"Sun","year":"2005","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2010.100048_bib32","first-page":"2577","article-title":"Identification of melanoma-associated antigens using fixed tissue screening of antibodies","volume":"44","author":"Atkinson","year":"1984","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2010.100048_bib33","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/hyb.1985.4.243","article-title":"Monoclonal antibody to a highly glycosylated protein reacts in fixed tissue with melanoma and other tumors","volume":"4","author":"Atkinson","year":"1985","journal-title":"Hybridoma"},{"key":"10.2353\/ajpath.2010.100048_bib34","first-page":"241","article-title":"Decreased expression of human melanoma-associated antigen ME491 along the progression of melanoma pre-canceroses to invasive and metastatic melanomas","volume":"3","author":"Kondoh","year":"1993","journal-title":"Melanoma Res"},{"key":"10.2353\/ajpath.2010.100048_bib35","first-page":"1751","article-title":"Correlation of KAI1\/CD82 gene expression with good prognosis in patients with non-small cell lung cancer","volume":"56","author":"Adachi","year":"1996","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2010.100048_bib36","first-page":"4876","article-title":"KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases","volume":"56","author":"Guo","year":"1996","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2010.100048_bib37","first-page":"5724","article-title":"Loss of KAI1 expression in the progression of colorectal cancer","volume":"59","author":"Lombardi","year":"1999","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2010.100048_bib38","first-page":"3424","article-title":"KAI1 protein is down-regulated during the progression of human breast cancer","volume":"6","author":"Yang","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.2353\/ajpath.2010.100048_bib39","doi-asserted-by":"crossref","first-page":"8886","DOI":"10.1073\/pnas.132253599","article-title":"Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes","volume":"99","author":"Lossos","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2010.100048_bib40","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1182\/asheducation-2005.1.314","article-title":"Biology and management of histologic transformation of indolent lymphoma","author":"Freedman","year":"2005","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.2353\/ajpath.2010.100048_bib41","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1200\/JCO.2006.09.3260","article-title":"Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma","volume":"25","author":"Montoto","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.2353\/ajpath.2010.100048_bib42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1200\/JCO.1983.1.1.11","article-title":"Histologic conversion in the non-Hodgkin's lymphomas","volume":"1","author":"Acker","year":"1983","journal-title":"J Clin Oncol"},{"key":"10.2353\/ajpath.2010.100048_bib43","first-page":"4127","article-title":"Motility related protein 1 (MRP-1\/CD9) expression: inverse correlation with metastases in breast cancer","volume":"55","author":"Miyake","year":"1995","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2010.100048_bib44","first-page":"6040","article-title":"Reduced motility related protein-1 (MRP-1\/CD9) gene expression as a factor of poor prognosis in non-small cell lung cancer","volume":"55","author":"Higashiyama","year":"1995","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2010.100048_bib45","first-page":"2593","article-title":"Differential display cloning identifies motility-related protein (MRP1\/CD9) as highly expressed in primary compared with metastatic human colon carcinoma cells","volume":"57","author":"Cajot","year":"1997","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2010.100048_bib46","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1006\/gyno.2002.6729","article-title":"Loss of expression and altered localization of KAI1 and CD9 protein are associated with epithelial ovarian cancer progression","volume":"86","author":"Houle","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.2353\/ajpath.2010.100048_bib47","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1158\/1078-0432.CCR-06-1692","article-title":"Down-regulation of CD9 expression during prostate carcinoma progression is associated with CD9 mRNA modifications","volume":"13","author":"Wang","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.2353\/ajpath.2010.100048_bib48","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1158\/1078-0432.CCR-07-4489","article-title":"Epigenetic silencing of the tetraspanin CD9 during disease progression in multiple myeloma cells and correlation with survival","volume":"14","author":"De Bruyne","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.2353\/ajpath.2010.100048_bib49","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1158\/0008-5472.CAN-06-3090","article-title":"Adenoviral transduction of MRP-1\/CD9 and KAI1\/CD82 inhibits lymph node metastasis in orthotopic lung cancer model","volume":"67","author":"Takeda","year":"2007","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2010.100048_bib50","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1002\/ijc.22902","article-title":"The tetraspanin CD9 inhibits the proliferation and tumorigenicity of human colon carcinoma cells","volume":"121","author":"Ovalle","year":"2007","journal-title":"Int J Cancer"},{"key":"10.2353\/ajpath.2010.100048_bib51","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/sj.bjc.6603964","article-title":"Colocalisation of CD9 and mortalin in CD9-induced mitotic catastrophe in human prostate cancer cells","volume":"97","author":"Zvereff","year":"2007","journal-title":"Br J Cancer"},{"key":"10.2353\/ajpath.2010.100048_bib52","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/sj.leu.2400564","article-title":"Establishment and characterization of a human stroma-dependent myeloma cell line (MM5.1) and its stroma-independent variant (MM5.2)","volume":"11","author":"Van Riet","year":"1997","journal-title":"Leukemia"},{"key":"10.2353\/ajpath.2010.100048_bib53","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1038\/sj.leu.2404343","article-title":"Endothelial cell-driven regulation of CD9 or motility-related protein-1 expression in multiple myeloma cells within the murine 5T33MM model and myeloma patients","volume":"20","author":"De Bruyne","year":"2006","journal-title":"Leukemia"},{"key":"10.2353\/ajpath.2010.100048_bib54","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.4049\/jimmunol.152.6.2768","article-title":"CD9-regulated adhesion. Anti-CD9 monoclonal antibody induce pre-B cell adhesion to bone marrow fibroblasts through de novo recognition of fibronectin","volume":"152","author":"Masellis-Smith","year":"1994","journal-title":"J Immunol"},{"key":"10.2353\/ajpath.2010.100048_bib55","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1182\/blood.V98.13.3717","article-title":"Regulatory role of tetraspanin CD9 in tumor-endothelial cell interaction during transendothelial invasion of melanoma cells","volume":"98","author":"Longo","year":"2001","journal-title":"Blood"},{"key":"10.2353\/ajpath.2010.100048_bib56","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1182\/blood-2004-09-3606","article-title":"Endothelial tetraspanin microdomains regulate leukocyte firm adhesion during extravasation","volume":"105","author":"Barreiro","year":"2005","journal-title":"Blood"},{"key":"10.2353\/ajpath.2010.100048_bib57","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1083\/jcb.128.5.929","article-title":"The membrane protein CD9\/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor","volume":"128","author":"Higashiyama","year":"1995","journal-title":"J Cell Biol"},{"key":"10.2353\/ajpath.2010.100048_bib58","doi-asserted-by":"crossref","first-page":"18284","DOI":"10.1074\/jbc.M907971199","article-title":"Importance of the major extracellular domain of CD9 and the epidermal growth factor (EGF)-like domain of heparin-binding EGF-like growth factor for up-regulation of binding and activity","volume":"275","author":"Nakamura","year":"2000","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2010.100048_bib59","first-page":"1507","article-title":"Expression of transmembrane 4 superfamily member, CD9, is related to improved progression-free survival in patients with diffuse non-Hodgkin's lymphoma","volume":"5","author":"Yau","year":"1998","journal-title":"Oncol Rep"},{"key":"10.2353\/ajpath.2010.100048_bib60","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1038\/sj.onc.1210041","article-title":"Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer","volume":"26","author":"Zhong","year":"2007","journal-title":"Oncogene"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010600934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010600934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:47:13Z","timestamp":1762080433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944010600934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0002944010600934"],"URL":"https:\/\/doi.org\/10.2353\/ajpath.2010.100048","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Down-Regulation of CD9 Expression and its Correlation to Tumor Progression in B Lymphomas","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.2353\/ajpath.2010.100048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}